Sep 30, 2016

ANI Pharmaceuticals Q3 2016 Earnings Report

Total Revenue
$38.5M
Previous year: $20M
+92.9%
EPS
$1.09
Previous year: $0.8
+36.3%
Gross Profit
$21.9M
Previous year: $16.7M
+30.8%
Cash and Equivalents
$16.2M
Previous year: $151M
-89.3%
Free Cash Flow
-$5K
Previous year: $9.47M
-100.1%
Total Assets
$319M
Previous year: $283M
+12.7%

ANI Pharmaceuticals

ANI Pharmaceuticals